Baird lowered the firm’s price target on Genpact (G) to $50 from $56 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks